We combine oncology expertise with advanced technology and analytics to organize real world data in order to guide decisions and actions.
Together, we can bring clarity to cancer care.
We curate EHR data that can be used to drive research and standardization in order to improve patient outcomes while also reducing costs at your institution.
We make clinical sense of claims data, providing insight into performance and related outcomes across sites in order to support value-based payment models.
Our deeply curated real world data accelerates drug development informing the decisions and actions that will deliver the best drugs to patients faster and at a lower cost.
Almost 10% of the world’s population suffers from a type of blood cancer. And despite popular opinion, there are actually hundreds of different types of blood cancer, not just leukemia and lymphoma.
But are we doing everything in our power when developing clinical trials to improve cancer treatment? Could we include diversity and make trials more accessible to everyone? Dr. Gwen Nichols thinks we have more work to do in the blood cancer space.
COTA announced findings from a study that found 66% of cancer patients and families surveyed think the speed of clinical trials for cancer treatments remains far too slow. Read more of the findings from the study, which surveyed 1,110 Americans who’ve either had cancer or who’ve had someone in their immediate family with cancer.
Let’s work together to transform cancer care.
